UBS Group’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $108M | Sell |
2,028,887
-127,519
| -6% | -$6.8M | 0.02% | 741 |
|
|
2025
Q1 | $87.3M | Buy |
2,156,406
+1,784,562
| +480% | +$72.2M | 0.02% | 807 |
|
|
2024
Q4 | $10.3M | Buy |
371,844
+277,043
| +292% | +$7.71M | ﹤0.01% | 2303 |
|
|
2024
Q3 | $2.72M | Buy |
94,801
+23,690
| +33% | +$680K | ﹤0.01% | 2787 |
|
|
2024
Q2 | $1.67M | Sell |
71,111
-136,890
| -66% | -$3.21M | ﹤0.01% | 3005 |
|
|
2024
Q1 | $5.25M | Sell |
208,001
-58,385
| -22% | -$1.47M | ﹤0.01% | 2145 |
|
|
2023
Q4 | $6.22M | Buy |
266,386
+207,983
| +356% | +$4.86M | ﹤0.01% | 1811 |
|
|
2023
Q3 | $2.95M | Buy |
58,403
+31,968
| +121% | +$1.62M | ﹤0.01% | 2246 |
|
|
2023
Q2 | $1.23M | Sell |
26,435
-66,997
| -72% | -$3.13M | ﹤0.01% | 3119 |
|
|
2023
Q1 | $3.57M | Sell |
93,432
-45,548
| -33% | -$1.74M | ﹤0.01% | 2107 |
|
|
2022
Q4 | $7.62M | Buy |
138,980
+135,262
| +3,638% | +$7.41M | ﹤0.01% | 1524 |
|
|
2022
Q3 | $127K | Buy |
3,718
+218
| +6% | +$7.45K | ﹤0.01% | 4456 |
|
|
2022
Q2 | $33K | Sell |
3,500
-63,065
| -95% | -$595K | ﹤0.01% | 5268 |
|
|
2022
Q1 | $945K | Buy |
66,565
+9,725
| +17% | +$138K | ﹤0.01% | 3281 |
|
|
2021
Q4 | $1.2M | Buy |
56,840
+13,588
| +31% | +$288K | ﹤0.01% | 3301 |
|
|
2021
Q3 | $967K | Buy |
43,252
+32,951
| +320% | +$737K | ﹤0.01% | 3281 |
|
|
2021
Q2 | $255K | Sell |
10,301
-18,308
| -64% | -$453K | ﹤0.01% | 4172 |
|
|
2021
Q1 | $830K | Buy |
28,609
+22,455
| +365% | +$651K | ﹤0.01% | 3527 |
|
|
2020
Q4 | $159K | Buy |
6,154
+4,463
| +264% | +$115K | ﹤0.01% | 4408 |
|
|
2020
Q3 | $52K | Buy |
1,691
+239
| +16% | +$7.35K | ﹤0.01% | 4767 |
|
|
2020
Q2 | $36K | Buy |
1,452
+441
| +44% | +$10.9K | ﹤0.01% | 5291 |
|
|
2020
Q1 | $21K | Sell |
1,011
-2,250
| -69% | -$46.7K | ﹤0.01% | 5549 |
|
|
2019
Q4 | $72K | Sell |
3,261
-2,847
| -47% | -$62.9K | ﹤0.01% | 5119 |
|
|
2019
Q3 | $139K | Buy |
6,108
+4,990
| +446% | +$114K | ﹤0.01% | 4630 |
|
|
2019
Q2 | $21K | Buy |
+1,118
| New | +$21K | ﹤0.01% | 5703 |
|